Advertisement
FDA
FDA
06/05/2019
After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.
06/05/2019
Seizure
Seizure
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
Multiple Sclerosis
Multiple Sclerosis
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018
Migraine
Migraine
10/01/2018
The new humanized monoclonal antibody acts by reducing the effect of CGRP, which is believed to have a physiologic role in migraine.
10/01/2018
Migraine
Migraine
09/17/2018
The FDA has approved a new migraine injection available in weekly and monthly dosing options.
09/17/2018
Epilepsy
Epilepsy
08/22/2018
The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.
08/22/2018
FDA
FDA
08/10/2018
The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.
08/10/2018
prevention
prevention
05/18/2018
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
05/18/2018
Epilepsy
Epilepsy
04/20/2018
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy. ...
04/20/2018
FDA
FDA
02/27/2018
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
02/27/2018